BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 18046294)

  • 1. Critical care of HIV infected patients in the highly active antiretroviral therapy era.
    Corona A; Raimondi F
    Minerva Anestesiol; 2007 Dec; 73(12):635-45. PubMed ID: 18046294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caring for HIV-infected patients in the ICU in the highly active antiretroviral therapy era.
    Corona A; Raimondi F
    Curr HIV Res; 2009 Nov; 7(6):569-79. PubMed ID: 19929791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Khouli H; Afrasiabi A; Shibli M; Hajal R; Barrett CR; Homel P
    J Intensive Care Med; 2005; 20(6):327-33. PubMed ID: 16280405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit.
    Palacios R; Hidalgo A; Reina C; de la Torre M; Márquez M; Santos J
    HIV Med; 2006 Apr; 7(3):193-6. PubMed ID: 16494634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changing epidemiology of HIV-infected patients in the intensive care unit.
    Akgün KM; Pisani M; Crothers K
    J Intensive Care Med; 2011; 26(3):151-64. PubMed ID: 21436170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical care of HIV-infected patients: still a dilemma for Italian intensivists--results of a multicentre survey.
    Corona A; Raimondi F
    Eur J Anaesthesiol; 2010 Apr; 27(4):377-82. PubMed ID: 20090538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of HIV-infected patients admitted to the intensive care unit in the era of highly active antiretroviral therapy.
    Adlakha A; Pavlou M; Walker DA; Copas AJ; Dufty N; Batson S; Edwards SG; Singer M; Miller RF
    Int J STD AIDS; 2011 Sep; 22(9):498-504. PubMed ID: 21890545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical care of immunocompromised patients: human immunodeficiency virus.
    Rosen MJ; Narasimhan M
    Crit Care Med; 2006 Sep; 34(9 Suppl):S245-50. PubMed ID: 16917430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current issues in critical care of the human immunodeficiency virus-infected patient.
    Morris A; Masur H; Huang L
    Crit Care Med; 2006 Jan; 34(1):42-9. PubMed ID: 16374154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life-threatening complications of HIV infection.
    Davaro RE; Thirumalai A
    J Intensive Care Med; 2007; 22(2):73-81. PubMed ID: 17456727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiretroviral therapy in critically ill patients: a French national study].
    Dinh A; Salomon J; Vuagnat A; De Truchis P; Maury E; Bernard L
    Med Mal Infect; 2007 Dec; 37(12):809-15. PubMed ID: 17628372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs.
    Muga R; Langohr K; Tor J; Sanvisens A; Serra I; Rey-Joly C; Muñoz A
    Clin Infect Dis; 2007 Aug; 45(3):370-6. PubMed ID: 17599317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy.
    Dickson SJ; Batson S; Copas AJ; Edwards SG; Singer M; Miller RF
    Thorax; 2007 Nov; 62(11):964-8. PubMed ID: 17517829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
    Hung CC; Hung MN; Hsueh PR; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Huang YT; Lo YC; Hsiao CF; Chang SC
    Clin Infect Dis; 2007 Sep; 45(5):e60-7. PubMed ID: 17682981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral manifestations in human immunodeficiency virus infected children in highly active antiretroviral therapy era.
    dos Santos Pinheiro R; França TT; Ribeiro CM; Leão JC; de Souza IP; Castro GF
    J Oral Pathol Med; 2009 Sep; 38(8):613-22. PubMed ID: 19614862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status.
    Kwara A; Flanigan TP; Carter EJ
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):248-57. PubMed ID: 15786886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncologic complications of human immunodeficiency virus infection: changing epidemiology, treatments, and special considerations in the era of highly active antiretroviral therapy.
    Klibanov OM; Clark-Vetri R
    Pharmacotherapy; 2007 Jan; 27(1):122-36. PubMed ID: 17192166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of transplantation in HIV patients during the HAART era.
    Pelletier SJ; Norman SP; Christensen LL; Stock PG; Port FK; Merion RM
    Clin Transpl; 2004; ():63-82. PubMed ID: 16704139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cutaneous drug reactions in HIV-infected patients in the HAART era].
    Blanes M; Belinchón I; Portilla J
    Actas Dermosifiliogr; 2009 May; 100(4):253-65. PubMed ID: 19463228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
    Madeddu G; Porqueddu EM; Cambosu F; Saba F; Fois AG; Pirina P; Mura MS
    Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.